A detailed history of Jacobs Levy Equity Management, Inc transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,260,017 shares of SAGE stock, worth $7.07 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,260,017
Previous 1,425,378 11.6%
Holding current value
$7.07 Million
Previous $15.5 Million 41.31%
% of portfolio
0.04%
Previous 0.07%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.02 - $13.08 $1.16 Million - $2.16 Million
-165,361 Reduced 11.6%
1,260,017 $9.08 Million
Q2 2024

Aug 14, 2024

BUY
$10.58 - $17.9 $9.21 Million - $15.6 Million
870,165 Added 156.73%
1,425,378 $15.5 Million
Q1 2024

May 15, 2024

SELL
$18.62 - $26.95 $3.49 Million - $5.06 Million
-187,645 Reduced 25.26%
555,213 $10.4 Million
Q4 2023

Feb 14, 2024

BUY
$17.1 - $22.26 $6.01 Million - $7.83 Million
351,627 Added 89.88%
742,858 $16.1 Million
Q3 2023

Nov 16, 2023

BUY
$16.75 - $48.98 $6.55 Million - $19.2 Million
391,231 New
391,231 $8.05 Million
Q2 2022

Aug 15, 2022

SELL
$27.52 - $37.99 $2.35 Million - $3.25 Million
-85,572 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$30.71 - $45.71 $4.1 Million - $6.1 Million
-133,479 Reduced 60.94%
85,572 $2.83 Million
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $6.27 Million - $7.97 Million
169,210 Added 339.5%
219,051 $9.32 Million
Q3 2021

Nov 15, 2021

BUY
$40.26 - $57.37 $2.01 Million - $2.86 Million
49,841 New
49,841 $2.21 Million
Q2 2021

Aug 16, 2021

SELL
$54.88 - $79.29 $687,097 - $992,710
-12,520 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$70.65 - $96.76 $15.7 Million - $21.5 Million
-222,419 Reduced 94.67%
12,520 $937,000
Q4 2020

Feb 16, 2021

SELL
$58.41 - $89.06 $1.39 Million - $2.13 Million
-23,880 Reduced 9.23%
234,939 $20.3 Million
Q3 2020

Nov 16, 2020

BUY
$41.13 - $62.45 $104,634 - $158,872
2,544 Added 0.99%
258,819 $15.8 Million
Q2 2020

Aug 17, 2020

BUY
$25.95 - $43.15 $5.44 Million - $9.05 Million
209,759 Added 450.94%
256,275 $10.7 Million
Q1 2020

May 15, 2020

BUY
$26.15 - $77.24 $1.07 Million - $3.17 Million
41,062 Added 752.88%
46,516 $1.34 Million
Q4 2019

Feb 14, 2020

BUY
$60.18 - $154.77 $328,221 - $844,115
5,454 New
5,454 $394,000
Q2 2018

Aug 14, 2018

SELL
$140.36 - $175.76 $301,774 - $377,884
-2,150 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$152.15 - $192.33 $327,122 - $413,509
2,150 New
2,150 $346,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $333M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.